Download the eBook to learn more about accelerating gene therapy developments as well as manufacturing solutions, the outcomes, successes, and possible pitfalls in gene therapy research.

The advancement of viral-vector gene therapies has enabled the industry to evolve and refine manufacturing scale-up approaches to generate viral vectors for a multitude of applications and target cells. With the rapid forward movement of the field as a whole, it is critical to understand and consider variables that can affect scale up and standardization of viral vector production in the commercial setting.

In this eBook, we delve further into accelerating gene therapy developments, as well as manufacturing solutions, the outcomes, successes, and possible pitfalls in gene therapy research.

Contents include:

• Accelerating gene therapy development with complete manufacturing solutions: an interview with Brandon Pence, Thermo Fisher Scientific
• Application Note: The Viral Vector HEK Media Panel addresses HEK293 cell lineage diversity in AAV production through basal screening
• Infoposter: Gene Therapy Roadmap
• Articles:
  • Optimizing AAV manufacture
  • The role of gene therapy as a valuable treatment modality for multiple spinal pathologies
  • Virus-mimicking nanocarriers for the intracellular delivery of therapeutic biomolecules

(*Indicates a mandatory field)

First Name*

Last Name*

Telephone*

Email*

Job Role*

Please selectCEO / COO / PresidentCore Facility/Service ProviderDepartment HeadDirectorFaculty / EducatorLab ManagerManagerPhysician / Medical DoctorPostdoctoral FellowPrincipal InvestigatorProject / Program ManagerPurchaser / ProcurerResearch Assistant / Lab TechnicianScientist / Associate ScientistStudent / Graduate StudentVice PresidentOther

Institution*

City*

Country/Region*

Please selectAfghanistanAland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaireBosnia & HerzegovinaBotswanaBouvet IslandBrasilBritish Indian OceanBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColumbiaComorosCongoCook IslandsCosta RicaCôte D'IvoireCroatiaCuracaoCyprusCzech RepublicDemocratic Republic of CongoDenmarkDjiboutiDominicaDominican RepublicTIMOR-LESTEEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFederated States of MicronesiaFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuianaGuineaGuinea - BissauHaitiHeard Island and McDonald IslandsHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxemburgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilipinesPitcairn IslandsPolandPortugalPuerto RicoQatarRéunionRomaniaRussiaRwandaSaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSan MarinoSão Tomé and PríncipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSaint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSamoaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUnited KingdomUkraineUnited Arab EmiratesUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVatican CityVenezuelaViet NamVirgin IslandsWallis and FutunaWestern SaharaYemenZambiaZimbabwe

What gene modification modality are you working with? Check all that apply*

Adeno-associated Virus (AAV)

Lentivirus (LV)

Non-viral- delivery

Other

Would you like to schedule a product demo or request pricing information?*

Yes

No

What is your purchase timeline?*

0-6 months

7-12 months

12 months or more

Not planning on making a purchase

Submit